1-5 of 5
Vincent Vinciguerra
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3150: Computational cohort discovery and coordinator-led validation to navigate potential research candidates to clinical trials

Yonah Ziemba, Kaitlin Parnahay, Paul Ward, Nalan Yurtsever, Sharon Fox, Cheryl Schleicher, Priya Singh-Shiwsankar, Vincent Vinciguerra, Joseph Herman, James M. Crawford, Daniel A. King
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3150.
https://doi.org/10.1158/1538-7445.AM2023-3150
Published: 04 April 2023
View articletitled, Abstract 3150: Computational cohort discovery and coordinator-led validation to navigate potential research candidates to clinical trials
Journal Articles

Isolation of a Novel Gene, TSP50, by a Hypomethylated DNA Fragment in Human Breast Cancer

Liming Yuan, Jidong Shan, Dwight De Risi, John Broome, John Lovecchio, David Gal, Vincent Vinciguerra, Hao-peng Xu
Journal: Cancer Research
Cancer Res (1999) 59 (13): 3215–3221.
Published: 01 July 1999
View articletitled, Isolation of a Novel Gene, TSP50, by a Hypomethylated DNA Fragment in Human Breast Cancer
Open the PDF for Isolation of a Novel Gene, TSP50, by a Hypomethylated DNA Fragment in Human Breast Cancer in another window
Journal Articles

Pharmacokinetic and Phase I Evaluation of Esorubicin (4′-Deoxydoxorubicin) by Continuous Infusion over Forty-eight Hours in Patients with Leukemia

Willi Kreis, Cheryl Rottach, Daniel R. Budman, Keith Chan, Philip Schulman, Steven L. Allen, Lora Weiselberg, Vincent Vinciguerra
Journal: Cancer Research
Cancer Res (1988) 48 (19): 5580–5584.
Published: 01 October 1988
View articletitled, Pharmacokinetic and Phase I Evaluation of Esorubicin (4′-Deoxydoxorubicin) by Continuous Infusion over Forty-eight Hours in Patients with Leukemia
Open the PDF for Pharmacokinetic and Phase I Evaluation of Esorubicin (4′-Deoxydoxorubicin) by Continuous Infusion over Forty-eight Hours in Patients with Leukemia in another window
Journal Articles

Effect of Tetrahydrouridine on the Clinical Pharmacology of 1-β-d-Arabinofuranosylcytosine When Both Drugs Are Coinfused over Three Hours1

Willi Kreis, Keith Chan, Daniel R. Budman, Phillip Schulman, Steven Allen, Lora Weiselberg, Stuart Lichtman, Vicki Henderson, Jean Freeman, Margaret Deere, Michael Andreeff, Vincent Vinciguerra
Journal: Cancer Research
Cancer Res (1988) 48 (5): 1337–1342.
Published: 01 March 1988
View articletitled, Effect of Tetrahydrouridine on the Clinical Pharmacology of 1-β-d-Arabinofuranosylcytosine When Both Drugs Are Coinfused over Three Hours1
Open the PDF for Effect of Tetrahydrouridine on the Clinical Pharmacology of 1-β-d-Arabinofuranosylcytosine When Both Drugs Are Coinfused over Three Hours1 in another window
Journal Articles

Pharmacokinetics of Low-Dose 1-β-d-Arabinofuranosylcytosine Given by Continuous Intravenous Infusion over Twenty-one Days1

Willi Kreis, Farida Chaudhri, Keith Chan, Steven Allen, Daniel R. Budman, Philip Schulman, Lora Weiselberg, Jean Freeman, Margaret Deere, Vincent Vinciguerra
Journal: Cancer Research
Cancer Res (1985) 45 (12_Part_1): 6498–6501.
Published: 01 December 1985
View articletitled, Pharmacokinetics of Low-Dose 1-β-d-Arabinofuranosylcytosine Given by Continuous Intravenous Infusion over Twenty-one Days1
Open the PDF for Pharmacokinetics of Low-Dose 1-β-d-Arabinofuranosylcytosine Given by Continuous Intravenous Infusion over Twenty-one Days1 in another window